Ticker brief
COGT COGENT BIOSCIENCES INC
Consumer, Non-cyclical · Biotechnology
last close
$38.69
1 day
+0.5%
14 days
+12.0%
mkt cap
$6.6B
signals 14d
17
authors 14d
8
Sentiment — last 14 days
daily mean sentiment, 2026-06-20 → 2026-06-30 · now +0.28 (−1 bearish … +1 bullish)
Who spoke8
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @2000STOCKMASTER | C | -4.19 | 5 | +0.54 |
| @semodough | C | -0.75 | 3 | +0.35 |
| @DeepValueReport | B | +2.52 | 2 | +0.20 |
| @Maximus_Holla | C | -0.48 | 2 | +0.28 |
| @kiantrades | C | -3.34 | 2 | +0.15 |
| @bioinvestor24 | A | +1.35 | 1 | +0.20 |
| @BioStocks | C | -0.39 | 1 | +0.25 |
| @OzmosiHealth | C | · | 1 | +0.35 |
Recent signals17of 17 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-06-30 | @kiantrades | -0.15 | Discloses COGT is second biggest holding, while saying it has been painful. | -0.0% | tweet ↗ |
| 2026-06-30 | @Maximus_Holla | +0.25 | COGT noted on the 40 level. | -0.0% | tweet ↗ |
| 2026-06-30 | @2000STOCKMASTER | +0.45 | Fragment suggests COGT is going to make a move, but text is garbled. | -0.0% | tweet ↗ |
| 2026-06-30 | @OzmosiHealth | +0.35 | Cogent announces NDA submission for bezuclastinib in advanced systemic mastocytosis. | -0.0% | tweet ↗ |
| 2026-06-30 | @semodough | +0.55 | COGT submission based on APEX pivotal trial with 65% and 81% ORR; reviews track for Q4 2026 approval. | -0.0% | tweet ↗ |
| 2026-06-30 | @semodough | +0.25 | States COGT has two PDUFAs this year and one more next year. | -0.0% | tweet ↗ |
| 2026-06-30 | @BioStocks | +0.25 | COGT submitted NDA for bezuclastinib in advanced systemic mastocytosis. | -0.0% | tweet ↗ |
| 2026-06-29 | @2000STOCKMASTER | +0.75 | GPCR VKTX SLS COGT could be bought out any day — Claims multiple biotech names could be bought out any day. | -0.1% | tweet ↗ |
| 2026-06-29 | @semodough | +0.25 | COGT has two bezuclastinib approval decisions expected on Nov 30 and Dec 30. | -0.1% | tweet ↗ |
| 2026-06-26 | @DeepValueReport | +0.40 | Lists highest-rated stocks in DVR database with scores. | +1.5% | tweet ↗ |
| 2026-06-25 | @2000STOCKMASTER | +0.80 | Predicts COGT is next to be bought out. | +1.8% | tweet ↗ |
| 2026-06-24 | @2000STOCKMASTER | +0.35 | Excited ticker cheer without concrete claim. | +3.1% | tweet ↗ |
| 2026-06-24 | @kiantrades | +0.45 | Expresses positive reaction to COGT move, but context is linked. | +3.1% | tweet ↗ |
| 2026-06-24 | @Maximus_Holla | +0.30 | Author says several tickers have been on a nice trend lately. | +3.1% | tweet ↗ |
| 2026-06-24 | @2000STOCKMASTER | +0.35 | Calls several names cheap and says MBX takeover coming. | +3.1% | tweet ↗ |
| 2026-06-24 | @DeepValueReport | +0.00 | Adds three tickers to watchlist without entry intent. | +3.1% | tweet ↗ |
| 2026-06-20 | @bioinvestor24 | +0.20 | Says REGN should acquire SYRE after ABBV/APGE deal; criticizes SNY BD. | +12.0% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.